Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bayer bitterfeld gmbh - germania - acid acetylsalicylicum - draj. - 500mg - alte analgezice si antipiretice acid salicilic si derivati

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

madaus gmbh - acidum acetylsalicylicum - caps. elib. prel. - 150mg - antitrombotice antiagregante plachetare, exclusiv heparina

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bayer bitterfeld gmbh - germania - combinatii (acidum acetylsalicylicum+acidum ascorbicum) - compr. eff. - 800mg/480mg - alte analgezice si antipiretice acid salicilic si derivati

Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

bayer s.r.l. - acid acetylsalicylicum + acid ascorbicum - comprimate efervescente - 800 mg/480 mg

Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

lek pharmaceuticals d.d./ljubljana - ketoprofenum - soluţie injectabilă / concentrat pentru soluţie perfuzabilă - 100 mg/2 ml

Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

rompharm company srl, sc - ketoprofenum - solutie injectabila - 50 mg/ml

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

bayer ag - riociguat - hipertensiune arterială, pulmonară - antihipertensive pentru hipertensiunea arterială pulmonară - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. eficacitatea a fost demonstrată într-un hap populației, inclusiv etiologii ale idiopatică sau ereditară pah sau htap asociată bolilor de țesut conjunctiv. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

canyon pharmaceuticals ltd. - desirudin - venous thrombosis - agenți antitrombotici - prevenirea trombozei venoase profunde la pacienții supuși unei intervenții chirurgicale de înlocuire a șoldului sau a genunchiului.

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - hipertensiune arterială, pulmonară - antihipertensive, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lek pharmaceuticals d.d. - slovenia - ketoprofenum - sol. inj. - 100mg/2ml - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic